يحاولGOLD- Free

Can Shorter Regimens Eliminate Drug-Resistant Tuberculosis?
BioSpectrum Asia|March 2024
The World Health Organization (WHO) has taken a significant stride in the battle against Tuberculosis (TB) by introducing shorter drug regimens, aiming to curb a disease that claims countless lives globally. This innovative approach addresses the urgent need for more efficient treatments, especially in regions where TB's toll is highest. With traditional therapies often posing risks to liver health, these shortened regimens offer hope, minimising such concerns while enhancing treatment adherence.
- Ayesha Siddiqui
Can Shorter Regimens Eliminate Drug-Resistant Tuberculosis?

Despite countries making bold commitments to end TB by 2030, in the Sustainable Development Goals (SDGs), the WHO End TB Strategy and the 2018 political declaration on the fight against TB, the epidemic shows no sign of slowing down. The deadly disease claimed 1.3 million lives in 2022. Drug-resistant TB is a growing threat - about 410,000 people had multidrug-resistant TB infections in 2022. In response to this pressing crisis, the WHO has been exploring various strategies to combat this deadly disease. Among these efforts is the development of shorter drug regimens, aiming to improve treatment outcomes and reduce the burden on patients.

Pretomanid and the Bedaquiline, Pretomanid, and Linezolid (BPaL) regimen, developed by the nonprofit TB Alliance, have transformed the treatment for drug-resistant TB and move us closer to achieving these goals, especially as they relate to the types of TB cases that have traditionally been most difficult and resource-intensive to treat.

Interim operational research results from 5 Central and Southeast Asian countries indicate that the BPaL regimen achieved a remarkable 94.5% cure rate in regions burdened by drugresistant TB (DR-TB). Operational research in these countries was part of the LIFT-TB programme, which provided funding, resources, technical assistance, and wide- ranging expertise from multiple partners for 7 countries with high burdens of DRTB (Indonesia, Kyrgyzstan, Myanmar, Philippines, Ukraine, Uzbekistan, and Vietnam) to advance the implementation and rollout of the BPaL regimen. India is also likely to roll out the new regimen soon.

هذه القصة مأخوذة من طبعة March 2024 من BioSpectrum Asia.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة March 2024 من BioSpectrum Asia.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

المزيد من القصص من BIOSPECTRUM ASIA مشاهدة الكل
"We are dedicated to helping people of all ages see brilliantly"
BioSpectrum Asia

"We are dedicated to helping people of all ages see brilliantly"

The global leader in eye care for over 75 years, Alcon Inc. strives to help eye care professionals strengthen their practices and serve patients better, improving visual health worldwide. Through its innovative eye care portfolios, Alcon has established operations in 56 countries and serves patients in 140 countries. Jason Hoffe, Vice President, APAC Vision Care, Alcon, responsible for driving the vision care business in the region shares opportunities exist for the company and new developments in eye healthcare that are cause for optimism for patients in the region.

time-read
5 mins  |
BioSpectrum Asia Jan 2025
Singapore Turns Tech Beacon with Revolutionary Pharma Manufacturing & Digital Transformation
BioSpectrum Asia

Singapore Turns Tech Beacon with Revolutionary Pharma Manufacturing & Digital Transformation

In the current pharmaceutical manufacturing environment, linking information technology (IT) with operational technology (OT) systems is increasingly vital. This integration enables a seamless exchange of information between these two historically separate domains - one focused on data management and the other on overseeing physical operations. This enables various aspects of the manufacturing process to gain insights from one another to boost efficiency and refine strategic decision-making. Digital transformation is essential for directing companies through the complexities of implementation and ensuring a seamless shift to a data-driven, digitally optimized manufacturing landscape.

time-read
6 mins  |
BioSpectrum Asia Jan 2025
Building the Future of Medicine
BioSpectrum Asia

Building the Future of Medicine

PRODUCT OF THE YEAR 2024 - Needle Free Injection System technology by IntegriMedical

time-read
4 mins  |
BioSpectrum Asia Jan 2025
Emerging Leader in Cell & Gene Therapy
BioSpectrum Asia

Emerging Leader in Cell & Gene Therapy

STARTUP OF THE YEAR 2024 - ImmunoACT

time-read
3 mins  |
BioSpectrum Asia Jan 2025
Improving Access for Respiratory Healthcare
BioSpectrum Asia

Improving Access for Respiratory Healthcare

STARTUP OF THE YEAR 2024 - Aevice Health

time-read
4 mins  |
BioSpectrum Asia Jan 2025
Making an Impact with a 'CliKX'
BioSpectrum Asia

Making an Impact with a 'CliKX'

Dr Lynne Lim, Co-Founder & Chief Executive Officer, NousQ

time-read
4 mins  |
BioSpectrum Asia Jan 2025
Eyeing 20-20 Vision of Excellence
BioSpectrum Asia

Eyeing 20-20 Vision of Excellence

Dr Jogin Desai, Co-Founder & Chief Executive Officer, Eyestem Research

time-read
4 mins  |
BioSpectrum Asia Jan 2025
Refining the Use of Radiation
BioSpectrum Asia

Refining the Use of Radiation

Dr Christian Behrenbruch, Managing Director and Group Chief Executive Officer (CEO), Telix Pharmaceuticals

time-read
3 mins  |
BioSpectrum Asia Jan 2025
Honouring Innovators in Asia's Thriving Life Sciences Sector
BioSpectrum Asia

Honouring Innovators in Asia's Thriving Life Sciences Sector

Asia has, indeed, become the new hub for growth and innovation, with no signs of losing steam. To recognise the Asian companies and individuals for their commendable performance and achievements during 2023 and 2024, BioSpectrum Asia Excellence Awards 2024 ceremony was held at Hotel Fort Canning in Singapore on December 6, 2024.

time-read
2 mins  |
BioSpectrum Asia Jan 2025
How To Control Indian Diabetes Growth
BioSpectrum Asia

How To Control Indian Diabetes Growth

World Diabetes Day, observed on November 14, reminds us of the growing impact of diabetes on global health and the urgent need for collective action to prevent, diagnose, and manage this chronic condition. In 2024, the theme 'Breaking Barriers, Bridging Gaps' underscores the critical importance of accessible, high-quality diabetes care, especially for underrepresented communities. The Government of India has taken many measures intending to reduce the prevalence of diabetes and alleviate its long-term complications, contributing to a healthier future for all citizens.

time-read
4 mins  |
December 2024

نحن نستخدم ملفات تعريف الارتباط لتقديم خدماتنا وتحسينها. باستخدام موقعنا ، فإنك توافق على ملفات تعريف الارتباط. يتعلم أكثر